PMID: 702701Nov 3, 1978Paper

Gentamicin tissue accumulation and nephrotoxic reactions

JAMA : the Journal of the American Medical Association
J J SchentagM E Plaut

Abstract

In 64 adults treated with gentamicin sulfate, peak and trough serum concentrations rose gradually and declined in two phases after the final dose. Seventeen patients experienced renal damage. The 17 patients had greater amounts of gentamicin in tissues even after the first dose and before any renal effects were noted. This pharmacokinetics analysis provided evidence that patients who experience gentamicin-related nephrotoxic effects while receiving recommended doses of gentamicin could be distinguished from patients with no toxic effects because they experienced abnormal tissue accumulation before detectable changes in renal function occurred.

Citations

Sep 1, 1979·Antimicrobial Agents and Chemotherapy·N Frimodt-MöllerP O Madsen
Oct 1, 1979·Antimicrobial Agents and Chemotherapy·J J SchentagW J Jusko
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·D E NixJ J Schentag
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·D E NixJ J Schentag
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·C E HalstensonW M Awni
Dec 1, 1987·Antimicrobial Agents and Chemotherapy·D L Frazier, J E Riviere
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·N E WinsladeJ J Schentag
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·J M GatellM T Jimenez de Anta
Nov 1, 1983·Archives of Disease in Childhood·A MulhallR Hurley
Feb 1, 1982·Archives of Disease in Childhood·H Feldman, J P Guignard
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·M AdelmanJ J Schentag
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·D J EdwardsJ J Schentag
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·D B HaugheyJ J Schentag
Nov 22, 2013·Inhalation Toxicology·Heather ConwayMatthew D Reed
Jan 1, 1979·Scandinavian Journal of Infectious Diseases. Supplementum·G Kahlmeter
Jan 1, 1987·Journal of Toxicology. Clinical Toxicology·W A WatsonJ J Schentag
Jul 1, 1982·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H D HumesT C Knauss
Dec 9, 2010·Basic & Clinical Pharmacology & Toxicology·Mahmoud M Mohy El-DinHeba A Abd El Razik
May 1, 1987·Journal of Clinical Pharmacology·K A Rodvold, R A Blum
Jan 1, 1980·Scandinavian Journal of Infectious Diseases. Supplementum·B Trollfors
Mar 1, 1991·Biopharmaceutics & Drug Disposition·J M LanaoJ M Tabernero
May 1, 1989·Equine Veterinary Journal·D J EdwardsJ D Baggott
Jun 10, 2010·Clinical Pharmacokinetics·Dion R Brocks, Reza Mehvar
Mar 1, 1982·British Journal of Clinical Pharmacology·L F Prescott
Jul 1, 1981·Annals of Clinical Biochemistry·J L Dols, A P van Zanten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Pharmacokinetics and Biopharmaceutics
J J SchentagL M Gerbracht
Antimicrobial Agents and Chemotherapy
J G DahlgrenW L Hewitt
© 2021 Meta ULC. All rights reserved